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Trends in Epidemiology of Neonatal Sepsis in a Tertiary Center  
in Korea: A 26-Year Longitudinal Analysis, 1980-2005
There were many reports of longitudinal changes in the causative organisms of neonatal 
sepsis in Western countries but few in Asia. We aimed to study longitudinal trends in the 
epidemiology of neonatal sepsis at Seoul National University Children’s Hospital (SNUCH), a 
tertiary center in Korea, and compared the results to previous studies of Western countries. 
The medical records of all of the neonates who were hospitalized at SNUCH from 1996 to 
2005 with positive blood cultures were reviewed. We also compared the findings to 
previous 16-yr (1980-1995). One hundred and forty-nine organisms were identified in 147 
episodes from 134 infants. In comparison with the previous 16-yr studies, there was a 
decrease in the number of Escherichia coli infections (16.2% vs 8.7%: odds ratio [OR] 
0.495; 95% confidence interval [CI], 0.255-0.962; P = 0.035), but an increase in 
Staphylococcus aureus (16.6% vs 25.5%: OR 1.720; 95% CI, 1.043-2.839; P = 0.033) 
and fungal infections (3.3% vs 18.7%: OR 6.740; 95% CI, 2.981-15.239; P < 0.001), 
predominantly caused by Candida species. In conclusion, the incidence of sepsis caused by 
E. coli decreases, but S. aureus and fungal sepsis increases significantly. Compared with 
Western studies, the incidence of sepsis caused by S. aureus and fungus has remarkably 
increased. 
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INTRODUCTION
Despite advances in perinatal care, neonatal sepsis is still a signif-
icant cause of morbidity and mortality in neonates. Over time, 
the causative organisms of neonatal sepsis has changed; thus, 
an institutional survey for infectious diseases is essential for the 
prevention and treatment of neonatal invasive infections. This 
is particularly important because regional differences in the 
specific causative organisms of neonatal sepsis have been pre-
viously reported (1-4). In the United States and European coun-
tries, the incidence of sepsis caused by group B Streptococcus 
(GBS) and Escherichia coli was decreased but the incidence of 
sepsis caused by coagulase negative Staphylococcus (CONS), 
Staphylococcus aureus and Candida species was increased (1, 4, 
5-7). Longitudinal changes in the incidence and etiology of neo-
natal sepsis has been well studied in North America and Europe, 
but not in many Asian countries.
  The neonatal intensive care unit (NICU) at Seoul National 
University Children’s Hospital (SNUCH), a tertiary NICU with 
300-600 annual admissions, has run ongoing surveillance for 
neonatal sepsis since 1980. During that time, the NICU has grad-
ually expanded, and severity of the patients increased. 
  In this report, we studied trends in the causative organisms of 
neonatal sepsis during 10 yr (1996-2005), and compared these 
trends with the previous 16-yr (1980-1995). We aimed to inves-
tigate a longitudinal change the causative organisms of neona-
tal sepsis in a tertiary center in Korea, and compared the results 
to previous studies of Western countries.
MATERIALS AND METHODS
Study population and microbiological tests
SNUCH has a tertiary NICU and receives both inborn patients 
from high-risk pregnancies and patients transported nation-
wide. All of the patients with blood cultures positive for any mi-
croorganism were identified from a retrospective review of the 
computerized records and logbooks of the Clinical Microbiolo-
gy Laboratory. The medical records of all of the neonates and 
infants who were inpatients in the NICU at SNUCH from 1996 
to 2005 (Period III) with positive blood cultures were reviewed. 
In addition, the medical records of all of the neonates who were 
less than 30 days of age with positive blood cultures and who 
were hospitalized outside of the NICU at SNUCH during the 
same period were reviewed. The data were compared with pre-
vious 2-period (Period I: 1980-1985, Period II: 1986-1995). 
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card (bioMerieux, Hazelwood, MO, USA). The antibiotic sus-
ceptibilities of the microorganisms were determined using the 
National Committee for Clinical Laboratory Standards (NCCLS) 
disk-diffusion method.
Definition
Fever (hyperthermia) and hypothermia were defined as having 
a core temperature of > 38.0°C and < 36.5°C, respectively. Apnea 
and bradycardia were included as clinical sign of sepsis only 
when the episodes were newly developed or the frequency and 
duration of the episodes increased. Hypoglycemia and hyper-
glycemia were defined as having a blood glucose of < 40 mg/dL 
and > 140 mg/dL, respectively (1).
  The criteria for the diagnosis of neonatal sepsis required iso-
lation of the microorganism from a blood culture and at least 
one clinical sign or symptom. For instance, in cases that had 
microorganisms common in skin contamination (e.g., diphthe-
roids, Bacillus species, Propionibacterium species or micrococ-
ci), a definition of sepsis was defined by documentation of a sign 
or symptom such as a fever, hypothermia, apnea, bradycardia, 
hypoglycemia and hyperglycemia along with either pathogen 
isolation from two blood cultures drawn on separate occasions 
or at least one peripheral blood culture from a patient with a cen-
tral venous catheter (8). Sepsis of CONS was reviewed using cri-
teria for the diagnosis of CONS defined by Bizzarro et al. (1). 
Sepsis was classified as early onset (EOS, ≤ 4 days of life), late 
onset (LOS, 5-30 days) and late, late onset (LLOS, > 30 days) (1).
  A sepsis-related death was defined when death occurred with-
in 7 days of a positive blood culture or when the clinical signs 
and symptoms of sepsis manifested (1). Sepsis-related mortali-
ty was calculated with the numerator representing the number 
of episodes of sepsis.
Statistics
The results were analyzed using SPSS version 12.0 (SPSS, Inc., 
Chicago, IL, USA). A Student’s t-test was used for comparison of 
the continuous variables. Pearson’s chi-square test or Fisher’s 
exact test (both two-sided) were used for comparison of the cat-
egorical variables when necessary. A value of P < 0.05 was con-
sidered to be statistically significant.
Ethics statement
The study protocol was approved by the institutional review 
boards of the Seoul National University Hospital (IRB No. H-0902-
033-272). Informed consent was waived by the IRB.
RESULTS
During 10 yr (Period III; 1996-2005) of this study, there was a 
total of 13,742 live births and a total of 1,479 outborn neonates 
in SNUCH. The numbers of live births declined from a total of 
1,888 in 1996 to a total of 1,001 in 2005. The inborn admission 
rate of extremely low birth weight (ELBW) infants (birth weight 
< 1,000 g) was 11.1 per 1,000 live births and the admission rate of 
infants weighing 1,000 g to 1,500 g was 19.4 per 1,000 live births. 
  A total of 502 blood cultures were positive from 310 patients. 
After a review of all 310 patients, 147 episodes were defined as 
neonatal sepsis from 134 patients. One hundred and twenty-six 
episodes (85.7%) occurred in patients who were in admitted to 
the NICU and 21 episodes occurred in patients who were ad-
mitted to the pediatric intensive care unit or pediatric wards. 
The percentage of male from all of the populations was 57.1%, 
the mean gestational age was 32 ± 5 weeks and the mean birth 
weight was 1,835 ± 1,113 g. The total sepsis rate of inborn neo-
nates was 5.9 per 1,000 live births and infants with a lower birth-
weight had higher sepsis rates (Table 1). There were 12 sepsis-
related mortality cases and the overall mortality rate was 9.0% 
(12/134).
  Apnea (19.7%) and fever (19.7%) were the most common symp-
toms of sepsis. There were significant differences in the symp-
toms of sepsis, based on the gestational age. Apnea and brady-
cardia were common in the total population, whereas fever was 
common only in the ≥ 32 weeks postmenstrual age (PMA) group, 
and hyperglycemia was more frequent in the < 32 weeks PMA 
group (Fig. 1). 
Table 1. Sepsis rates for inborn infants by birth weight (1996-2005)
Birth weight (g)
Number of  
live births
Number of inborn 
cases of sepsis 
(Episodes)
Cases per 1,000  
live births
< 750 68 16 (18) 235.3
750-999 85 13 (14) 152.9
1,000-1,499 267 30 (33) 112.4
1,500-1,999 368 8 (9) 21.7
≥ 2,000 12,954 14 (16) 1.1
Total 13,742 81 (90) 5.9
% *
*
Apnea
Bradycardia
Hypothermia Fever
Hypoglycemia
Hyperglycemia
35
30
25
20
15
10
5
0
Fig. 1. Comparison of the clinical symptoms of neonatal sepsis between early ages     
(< 32 weeks of PMA) and late ages (≥ 32 weeks of PMA). *P < 0.05. PMA, postmen-
strual age.
< 32 weeks of PMA
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  Of the 147 episodes of neonatal sepsis, 90 (61.1%) episodes 
were in the inborn neonates and 57 (38.9%) episodes were in the 
outborn cases (Table 2). Of the 90 episodes in the inborn neo-
nates, 7 (7.8%) were EOS, 63 (70.0%) were LOS and 20 (22.2%) 
were LLOS (Table 2). During the study period, 149 microorgan-
isms were isolated from the 147 episodes of sepsis. Gram-posi-
tive bacteria accounted for 65 (43.6%), Gram-negative bacteria 
for 56 (37.6%), and fungus for 28 (18.8%) episodes. The common 
microorganisms found were S. aureus (n = 38, 25.5%), Candida 
species (n = 25, 16.8%), Klebsiella pneumoniae (n = 19, 13.4%), E. 
Table 2. Causative organisms of neonatal sepsis at SNUCH (1996-2005)
Inborn
Outborn Overall
EOS LOS LLOS Total
Gram positive bacteria
   Staphylococcus aureus
   CONS
   GBS
   Streptococcus mitis
   Streptococcus hemolyticus
   Streptococcus pyogens
   Enterococcus faecalis 
   Enterococcus faecium
   Enterococcus species
5 (62.5)
1 (12.5)
1* (12.5)
1 (12.5)
1* (12.5)
1 (12.5)
24 (37.5)
15 (23.5)
4
† (6.2)
2 (3.1)
2 (3.1)
1 (1.6)
7 (35.0)
6 (30.0)
1 (5.0)
36 (39.1)
22 (23.9)
6 (6.5)
3 (3.2)
2 (2.2)
2 (2.2)
1 (1.1)
29 (50.9)
16 (28.1)
6 (10.5)
3 (5.2)
1 (1.8)
1 (1.8)
2 (3.5)
65 (43.6)
38 (25.5)
12 (8.0)
3 (2.0)
3 (2.0)
1 (0.7)
1 (0.7)
4 (2.7)
2 (1.3)
1 (0.7)
Gram negative bacteria
   Klebsiella pneumoniae
   Klebsiella oxytoca
   Escherichia coli
   Enterobacter cloacae
   Enterobacter aerogenes
   Acinetobacter baumannii
   Acinetobacter calcoaceticus
   Pseudomonas aeruginosa
   Pseudomonas fluorescens
   Stenotrophomonas maltophilia
   Serratia marcescens
   Burkholderia cepacia
2 (25.0)
 
 
1 (12.5)
1 (12.5)
 
 
 
 
 
 
 
 
23 (35.9)
8 (12.5)
 
4 (6.2)
2 (3.1)
 
5 (7.7)
1 (1.6)
1 (1.6)
 
1 (1.6)
 
1 (1.6)
8 (40.0)
5 (25.0)
 
1 (5.0)
 
1 (5.0)
 
 
 
 
 
 
1 (5.0)
33 (35.9)
13 (14.2)
 
6 (6.5)
3 (3.2)
1 (1.1)
5 (5.4)
1 (1.1)
1 (1.1)
 
1 (1.1)
 
2 (2.2)
23 (40.4)
6 (10.5)
1 (1.8)
7 (12.2)
 
 
1 (1.8)
 
5 (8.7)
1 (1.8)
1 (1.8)
1 (1.8)
56 (37.6)
19 (12.8)
1 (0.7)
13 (8.7)
3 (2.0)
1 (0.7)
6 (4.0)
1 (0.7)
6 (4.0)
1 (0.7)
2 (1.3)
1 (0.7)
2 (1.3)
Fungus
   Candida albicans
   Candida parapsilosis
   Candida tropicalis
   Candida glabrate
   Candida lambica
   Geotrichum canidum
   Malassezia furfur
  Malassezia species
1 (12.5)
1 (12.5)
 
 
 
 
 
 
 
17 (26.6)
9
† (14.1)
4 (6.2)
2 (3.1)
1 (1.6)
1 (1.6)
 
 
 
5 (25.0)
2 (10.0)
1 (5.0)
 
 
 
1 (5.0)
 
1 (5.0)
23 (25.0)
12 (13.0)
5 (5.4)
2 (2.2)
1 (1.1)
1 (1.1)
1 (1.1)
 
1 (1.1)
5 (8.7)
2 (3.5)
2 (3.5)
 
 
 
 
1 (1.8)
 
28 (18.8)
14 (9.3)
7 (4.7)
2 (1.3)
1 (0.7)
1 (0.7)
1 (0.7)
1 (0.7)
1 (0.7)
Total  8 (100.0) 64 (100.0) 20 (100.0) 92 (100.0) 57 (100.0) 149 (100.0)
Data presented as number (%). *Mixed infection: CONS + Enterococcus faecium; 
†Mixed infection: CONS + Candida albicans. SNUCH, Seoul National University Children’s 
Hospital; EOS, early onset sepsis; LOS, late onset sepsis; LLOS, late, late onset sepsis; CONS, coagulase-negative Staphylococcus; GBS, Group B Streptococcus.
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Fig. 2. Comparison of the percentage of the cause of neonatal sepsis; 1980-2005. Data presented as percent (%). CONS, coagulase-negative Staphylococcus; GBS, group-B 
Streptococcus. *P < 0.05 vs Period I+II and Period III; 
†P < 0.05 vs Period I and Period II; 
‡P < 0.05 vs Period I and Period III; 
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coli (n = 13, 8.7%) and CONS (n = 12, 8.1%) (Table 2). There were 
two episodes of mixed infections. One mixed infection was the 
EOS of CONS with Enterococcus faecium and the other mixed 
infection was the LOS of CONS with Candidia albicans.
  EOS in inborn neonates included 8 cases and had no GBS 
cases and no predominant microorganisms. The most common 
microorganism of 63 LOS cases was Candida species (n = 17, 
26.6%) followed by S. aureus (n = 15, 23.4%) and K. pneumoniae 
(n = 8, 12.5%). There were 20 episodes of LLOS, and the predom-
inant microorganisms were S. aureus (n = 6, 30.0%) and K. pneu-
moniae (n = 5, 25.0%). There were 57 episodes of neonatal sep-
sis in outborn neonates and the most common causative organ-
ism was S. aureus (n = 16, 28.1%). Most of the S. aureus isolates 
(36/38) were methicillin-resistant and all of the CONS isolates 
were methicillin-resistant. There were two episodes of mixed 
infections. 
  Fig. 2 shows the overall trend in sepsis cases over 26 yr in 
SNUCH. During the 26 yr, S. aureus was the most common caus-
ative organisms of neonatal sepsis. Compared to the decade 
just before the study period, the incidence of sepsis caused by  
S. aureus (Period I + II vs Period III: odds ratio [OR] 1.720; 95% 
confidence interval [CI], 1.043-2.839; P = 0.033) and fungus 
(Period I + II vs Period III: OR 6.740; 95% CI, 2.981-15.239; P < 
0.001) were increased, but the incidence of sepsis caused by E. 
coli (Period I + II vs Period III: OR 0.495; 95% CI, 0.255-0.962; P 
= 0.035) was decreased (Table 3). 
DISCUSSION
The reported incidence of neonatal sepsis varies from 2.8 to 8.1 
cases per 1,000 live births (9-11). The inborn neonatal sepsis rate 
for a recent 10-yr period at our center was 5.9 cases per 1,000 live 
births, and this result is similar to of the Yale New Haven Hospi-
Table 3. Comparison of ratio of causative organisms between each period
Causative organisms
Period I + II  
1980-1995 (n = 241)
Period III  
1996-2005 (n = 149)
P value
Odds ratio  
(95% confidence interval)
Preterm 102/224 (45.5) 89/134 (66.4)
Gram positive
   Staphylococcus aureus
   CONS
   GBS
   Enterococcus species
   Others
98 (40.7)
40 (16.6)
33 (13.7)
6 (2.5)
8 (3.3)
11 (4.6)
65 (43.6)
38 (25.5)
12 (8.0)
3 (2.0)
7 (4.7)
5 (3.4)
0.565
0.033
0.090
1.000
0.492
0.559
1.129 (0.747-1.707)
1.720 (1.043-2.839)
0.552 (0.276-1.106)
0.805 (0.198-3.268)
1.436 (0.510-4.044)
0.726 (0.247-2.132)
Gram negative
   Escherichia coli
   Klebsiella pneumoniae
   Enterobacter species
   Pseudomonas species
   Serratia species
   Others
135 (56.0)
39 (16.2)
46 (19.1)
21 (8.7)
12 (5.0)
8 (3.3)
9 (3.7)
56 (37.6)
13 (8.7)
19 (12.8)
4 (2.7)
7 (4.0)
1 (0.7)
12 (8.7)
0.000
0.035
0.103
0.019
0.900
0.162
0.066
0.473 (0.311-0.718)
0.495 (0.255-0.962)
0.620 (0.347-1.105)
0.289 (0.097-0.859)
0.941 (0.362-2.446)
0.197 (0.024-1.590)
2.258 (0.928-5.497)
Fungus
   Candida species
   Others
8 (3.3)
8 (3.3)
0 (0.0)
28 (18.7)
26 (17.4)
2 (1.3)
0.000
0.000
0.145
6.740 (2.981-15.239)
6.157 (2.706-14.006)
-
Data presented as number (%). CONS, coagulase-negative Staphylococcus; GBS, group-B Streptococcus.
tal (7.1 cases per 1,000 live births) (1).
  For the last 10 yr, most of the cases of inborn neonatal sepsis 
were LOS. There were only 7 (8.0%) cases of EOS out of 88 in-
born neonatal sepsis cases at SNUCH. In Korea, the estimated 
incidence of GBS infection in newborns has been much lower 
than in other countries (12), due to the low prevalence rate of 
GBS colonization in pregnant women (13, 14). In fact, there were 
only 3 GBS sepsis cases in our study and all of these cases were 
outborn and LOS. This result might contribute to Korea’s lower 
incidence of EOS compared to other countries (1, 15).
  Apnea, bradycardia, hyperglycemia and fever were common 
symptoms in neonates with sepsis. Apnea, bradycardia and hy-
perglycemia were more common in PMA < 32 weeks neonates. 
In contrast, a fever was more common symptom in PMA ≥ 32 
weeks neonates. These results indicate that very preterm infants 
(< 32 weeks of PMA) with sepsis tend to show non-specific symp-
toms rather than a typical infection sign such as a fever. There-
fore, careful evaluation of clinical status is important for the ear-
ly detection of infectious disease in preterm infants.
  The common causative organisms of neonatal sepsis were S. 
aureus, Candida species, K. pneumoniae, E. coli and CONS. Com-
pared to other studies from Korea, the frequency of CONS and 
GBS was lower, but the frequency of Klebsiella species and Can-
dida species was higher (15-17). These results may be due to 
the differences of characteristics of patients, policy of antibiotic 
uses and normal flora. Furthermore, our reports revealed that 
most S. aureus and CONS isolates were methicillin-resistant. 
This result reflects the observation that S. aureus and CONS col-
onization of infants hospitalized in the NICU was very preva-
lent. A higher rate of methicillin-resistant Gram-positive organ-
ism colonization in NICU infants has recently emerged world-
wide, and is the major cause of neonatal blood-stream infec-
tions. A chemotherapeutic strategy for neonatal sepsis should Shim GH, et al.  •  Neonatal Sepsis in a Tertiary Center in Korea
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be re-evaluated and the appropriate use of antibiotics must be 
re-emphasized. Prophylactic use of antibiotics and broad-spec-
trum antibiotics use should be minimized (18). 
  In comparison with previous data from our institution, the 
number of cases of E. coli was reduced, but the number of cases 
of S. aureus and fungal infections were increased (Fig. 2, Table 3) 
(19). This decline in E. coli cases and the increase in fungal cases 
is similar to other reports (1, 4-7, 20, 21). Previous studies have 
shown that the rising incidence of fungal infections is related to 
a higher survival rate of VLBW infants and an increase in the in-
cidence of prolonged use of broad-spectrum antibiotics (22-25). 
Over the last 10 yr, the Korean birth rate has decreased but the 
birth rate of preterm infants has increased. In SNUCH, the total 
number of preterm infants has increased and the infant surviv-
al rate has improved dramatically over the last 10 yr. A higher 
incidence of catheter uses, a longer duration of TPN uses and a 
longer duration of antibiotics uses were associated with an in-
creased survival rate of the VLBW infants especially the ELBW 
infants. Several studies have revealed that low birth weight and 
prematurity are significant risk factors for neonatal sepsis (26, 
27). In addition, our studies have shown that the inborn sepsis 
rate in infants with a birth weight < 1,500 g (152.4 cases per 1,000 
live births) was 84.7 times higher than that in infants with a birth 
weight ≥ 1,500 g (1.8 cases per l,000 live births). An increased 
fungal sepsis rate was associated with an increased survival of 
ELBW infants, resulting in a longer hospital stay. We also expe-
rienced an increased fungal sepsis rate over the study period. 
We recently introduced ‘fluconazole prophylaxis’ in the ELBW 
infants after the study period (28). Following this introduction, 
the fungal sepsis rate found in our institution dramatically de-
creased (data not shown). However, this result needs careful in-
terpretation because it might be due to a lowering of the overall 
sensitivity of microbiological culture for the detection of fungi 
in the blood, urine or cerebrospinal fluid (29).
  Compared to studies from Finland and the United States, the 
frequency of GBS, CONS, and E. coli was lower, but the frequen-
cy of Klebsiella species, Pseudomonas species, and Candida spe-
cies was higher (1, 4). These findings again emphasize the region-
al difference of sepsis-causing organisms and the importance 
of the establishment of a suitable strategy to diagnose neonatal 
sepsis by region. The longitudinal trends of decreased incidence 
of E. coli sepsis were comparable with Western studies. But our 
study showed increased incidence of sepsis caused by S. aureus 
and strikingly increased incidence of fungal sepsis, predomi-
nantly caused by Candida species (1, 4, 30).
  In conclusion, the incidence of sepsis caused by E. coli de-
creases, but S. aureus and fungal sepsis increased significantly. 
In contrast to Western studies, our study showed a higher rate 
of sepsis caused by S. aureus and Klebsiella species, and a lower 
rate of sepsis caused by CONS and GBS (1, 4). In addition, the 
incidence of sepsis caused by S. aureus and fungus has remark-
ably increased (1, 4, 30).
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We aimed to study longitudinal trends in the epidemiology of neonatal sepsis a tertiary center in Korea. The medical records of all 
of the neonates who were hospitalized at Seoul National University Children’s Hospital from 1996 to 2005 with positive blood 
cultures were reviewed. We also compared the findings to previous 16-yr (1980-1995). One hundred and forty-nine organisms 
were identified from 134 infants. In comparison with the previous 16-yr studies, there was a decrease in the number of Escherichia 
coli infections, but an increase in Staphylococcus aureus and fungal infections. In conclusion, the incidence of sepsis caused by E. 
coli decreases, but S. aureus and fungal sepsis increases significantly. Compared with Western studies, the incidence of sepsis 
caused by S. aureus and fungus has remarkably increased.